Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
34.55 USD | +3.66% | +32.02% | -4.95% |
May. 02 | Barrington Ups Price Target on SurModics to $71 From $70, Maintains Outperform Rating | MT |
May. 01 | Top Midday Gainers | MT |
Financials (USD)
Sales 2024 * | 123M | Sales 2025 * | 138M | Capitalization | 492M |
---|---|---|---|---|---|
Net income 2024 * | -10M | Net income 2025 * | 10M | EV / Sales 2024 * | 4 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.58 x |
P/E ratio 2024 * |
-35.3
x | P/E ratio 2025 * |
86.4
x | Employees | 376 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.25% |
Latest transcript on Surmodics, Inc.
1 day | +3.66% | ||
1 week | +32.02% | ||
Current month | +34.49% | ||
1 month | +28.11% | ||
3 months | +8.75% | ||
6 months | +16.49% | ||
Current year | -4.95% |
Managers | Title | Age | Since |
---|---|---|---|
Gary Maharaj
CEO | Chief Executive Officer | 61 | 10-12-26 |
Timothy Arens
DFI | Director of Finance/CFO | 57 | 07-01-31 |
Teri L. Sides
PRN | Corporate Officer/Principal | 55 | 18-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ronald Kalich
BRD | Director/Board Member | 77 | 14-02-16 |
Susan Knight
CHM | Chairman | 70 | 08-01-28 |
José Bedoya
BRD | Director/Board Member | 68 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.21% | 27 M€ | -4.49% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 34.55 | +3.66% | 380,999 |
24-05-01 | 33.33 | +29.74% | 256,570 |
24-04-30 | 25.69 | -0.62% | 65,825 |
24-04-29 | 25.85 | -1.22% | 23,946 |
24-04-26 | 26.17 | 0.00% | 22,671 |
Delayed Quote Nasdaq, May 02, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.95% | 492M | |
-3.77% | 184B | |
-1.77% | 107B | |
-1.43% | 69.44B | |
+2.06% | 50.37B | |
+9.43% | 44.82B | |
+3.40% | 41.53B | |
+3.04% | 26.73B | |
+4.64% | 26.84B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- SRDX Stock